Pieter Beerepoot
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Alpha-methyl-para-tyrosine and amphetamine ameliorate hyperactivity in a novel mouse model of dopamine transporter deficiency syndrome.
Journal: EMBO molecular medicine
Published: April 03, 2025
Molecular features of human pathological tau distinguish tauopathy-associated dementias.
Journal: Cell
Published: November 30, 2023
Alzheimer proteopathic tau seeds are biochemically a forme fruste of mature paired helical filaments.
Journal: Brain : a journal of neurology
Published: January 23, 2023
Structure-Activity Relationships of Dopamine Transporter Pharmacological Chaperones.
Journal: Frontiers in cellular neuroscience
Published: December 10, 2021
Tau PTM Profiles Identify Patient Heterogeneity and Stages of Alzheimer's Disease.
Journal: Cell
Published: March 03, 2020
Tau molecular diversity contributes to clinical heterogeneity in Alzheimer's disease.
Journal: Nature medicine
Published: June 28, 2019
Behavioral Effects of a Potential Novel TAAR1 Antagonist.
Journal: Frontiers in pharmacology
Published: February 03, 2018
Pharmacological Chaperones of the Dopamine Transporter Rescue Dopamine Transporter Deficiency Syndrome Mutations in Heterologous Cells.
Journal: The Journal of biological chemistry
Published: July 18, 2016
A β-lactamase based assay to measure surface expression of membrane proteins.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: February 23, 2015
Sustained N-methyl-d-aspartate receptor hypofunction remodels the dopamine system and impairs phasic signaling.
Journal: The European journal of neuroscience
Published: November 13, 2013
Last Updated: 09/26/2026